<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: archives of neurology</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia</title>
   	 <description>Depression in a group of Medicare recipients ages 65 years and older appears to be associated with prevalent mild cognitive impairment and an increased risk of dementia, according to a report published Online First by Archives of Neurology, a JAMA Network publication.</description>
     <link>http://medicalxpress.com/news/2012-12-late-life-depression-prevalent-mild-cognitive.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 31 Dec 2012 16:00:04 EST</pubDate>
	 <guid isPermaLink="false">news276174351</guid>
	 
</item>
<item>
     <title>Eye scan could help track progress of multiple sclerosis</title>
   	 <description>(HealthDay)—In-office eye scans that assess the thinning of the retina may also help doctors determine how fast multiple sclerosis (MS) is progressing in patients with the nervous system disease, a new study suggests.</description>
     <link>http://medicalxpress.com/news/2012-12-eye-scan-track-multiple-sclerosis.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 24 Dec 2012 18:07:39 EST</pubDate>
	 <guid isPermaLink="false">news275594846</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/eyescancould.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists image brain structures that deteriorate in Parkinson's</title>
   	 <description>A new imaging technique developed at MIT offers the first glimpse of the degeneration of two brain structures affected by Parkinson's disease.</description>
     <link>http://medicalxpress.com/news/2012-11-scientists-image-brain-deteriorate-parkinson.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 26 Nov 2012 16:26:17 EST</pubDate>
	 <guid isPermaLink="false">news273169560</guid>
	 
</item>
<item>
     <title>Aspirin resistance ups severity in acute ischemic stroke</title>
   	 <description>(HealthDay)—In patients with acute ischemic stroke, aspirin resistance is associated with increased stroke severity and infarct size, according to research published online Nov. 19 in the Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-11-aspirin-resistance-ups-severity-acute.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 21 Nov 2012 15:10:01 EST</pubDate>
	 <guid isPermaLink="false">news272728841</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/aspirinresis.jpg" width="90" height="90" />
</item>
<item>
     <title>Physical exercise improves gait speed, muscle strength, fitness in patients with Parkinson's disease</title>
   	 <description>Physical exercise, including treadmill, stretching and resistance exercises, appears to improve gait speed, muscle strength and fitness for patients with Parkinson disease (PD), according to a report of a randomized clinical trial published Online First by Archives of Neurology, a JAMA Network publication.</description>
     <link>http://medicalxpress.com/news/2012-11-physical-gait-muscle-strength-patients.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Mon, 05 Nov 2012 16:00:06 EST</pubDate>
	 <guid isPermaLink="false">news271337584</guid>
	 
</item>
<item>
     <title>Latrepirdine not effective in Huntington's disease</title>
   	 <description>(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease (HD), according to a study published online Oct. 29 in the Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-11-latrepirdine-effective-huntington-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 01 Nov 2012 19:40:01 EST</pubDate>
	 <guid isPermaLink="false">news271013882</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/latrepirdine.jpg" width="90" height="90" />
</item>
<item>
     <title>Study of patients ages 90 and older links poor physical performance, increased odds of dementia</title>
   	 <description>Poor physical performance on activities including walking was associated with increased odds of dementia in a study of individuals 90 years and older, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-10-patients-ages-older-links-poor.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 22 Oct 2012 16:00:11 EST</pubDate>
	 <guid isPermaLink="false">news270137022</guid>
	 
</item>
<item>
     <title>Study examines delayed, misdiagnosis of sporadic Jakob-Creutzfeldt disease</title>
   	 <description>A medical record review study of 97 patients with the fatal, degenerative brain disorder sporadic Jakob-Creutzfeldt disease (sCJD) suggests that a correct diagnosis of the disease was often delayed by a variety of misdiagnoses, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-09-misdiagnosis-sporadic-jakob-creutzfeldt-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 24 Sep 2012 16:00:07 EST</pubDate>
	 <guid isPermaLink="false">news267704801</guid>
	 
</item>
<item>
     <title>Less Alzheimer's pathology with angiotensin receptor blocker use</title>
   	 <description>(HealthDay)—In autopsy findings, patients treated with angiotensin receptor blockers (ARBs) show less Alzheimer's disease (AD)-related pathology, according to a study published online Sept. 10 in the Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-09-alzheimer-pathology-angiotensin-receptor-blocker.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Wed, 12 Sep 2012 11:30:03 EST</pubDate>
	 <guid isPermaLink="false">news266666081</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/lessalzheime.jpg" width="90" height="90" />
</item>
<item>
     <title>Five CSF markers differentiate dementia, parkinsonism</title>
   	 <description>(HealthDay)—Levels of five different cerebrospinal fluid (CSF) biomarkers are able to improve differentiation between common dementia and parkinsonian disorders, according to a study published online Aug. 27 in the Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-08-csf-markers-differentiate-dementia-parkinsonism.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 28 Aug 2012 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news265375345</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fivecsfmarke.jpg" width="90" height="90" />
</item>
<item>
     <title>Shortened telomere length tied to dementia, mortality risk</title>
   	 <description>(HealthDay) -- Shortened telomere length (TL) is associated with risks for dementia and mortality in a population of older adults, according to a study published online July 23 in the Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-07-shortened-telomere-length-tied-dementia.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 25 Jul 2012 13:30:01 EST</pubDate>
	 <guid isPermaLink="false">news262439857</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/shortenedtel.jpg" width="90" height="90" />
</item>
<item>
     <title>Strong communication between brain and muscle requires both having the protein LRP4</title>
   	 <description>Communication between the brain and muscle must be strong for us to eat, breathe or walk. Now scientists have found that a protein known to be on the surface of muscle cells must be present in both tissues to ensure the conversation is robust.</description>
     <link>http://medicalxpress.com/news/2012-07-strong-brain-muscle-requires-protein.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 11 Jul 2012 12:44:05 EST</pubDate>
	 <guid isPermaLink="false">news261229404</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/strongcommun.jpg" width="90" height="84" />
</item>
<item>
     <title>Study examines fingolimod therapy in patients with multiple sclerosis</title>
   	 <description>The medication fingolimod reduced inflammatory lesion activity and reduced brain volume loss in patients with multiple sclerosis who participated in a two-year placebo-controlled clinical trial and were assessed by magnetic resonance imaging (MRI) measures, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-07-fingolimod-therapy-patients-multiple-sclerosis.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 02 Jul 2012 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news260456972</guid>
	 
</item>
<item>
     <title>Diabetes, poor glucose control associated with greater cognitive decline in older adults</title>
   	 <description>Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a report published Online First by Archives of Neurology, a JAMA Network publication.</description>
     <link>http://medicalxpress.com/news/2012-06-diabetes-poor-glucose-greater-cognitive.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 18 Jun 2012 16:00:18 EST</pubDate>
	 <guid isPermaLink="false">news259250436</guid>
	 
</item>
<item>
     <title>Deep brain stimulation may hold promise for mild Alzheimer's disease</title>
   	 <description>A study on a handful of people with suspected mild Alzheimer's disease (AD) suggests that a device that sends continuous electrical impulses to specific &quot;memory&quot; regions of the brain appears to increase neuronal activity. Results of the study using deep brain stimulation, a therapy already used in some patients with Parkinson's disease and depression, may offer hope for at least some with AD, an intractable disease with no cure.</description>
     <link>http://medicalxpress.com/news/2012-05-deep-brain-mild-alzheimer-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 07 May 2012 16:00:17 EST</pubDate>
	 <guid isPermaLink="false">news255615020</guid>
	 
</item>
<item>
     <title>Clinical decline in Alzheimer's requires plaque and proteins</title>
   	 <description>According to a new study, the neuron-killing pathology of Alzheimer's disease (AD), which begins before clinical symptoms appear, requires the presence of both amyloid-beta (a-beta) plaque deposits and elevated levels of an altered protein called p-tau.</description>
     <link>http://medicalxpress.com/news/2012-04-clinical-decline-alzheimer-requires-plaque.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 23 Apr 2012 16:00:10 EST</pubDate>
	 <guid isPermaLink="false">news254397715</guid>
	 
</item>
<item>
     <title>Persistent ocular tremors appear to be associated with Parkinson's disease</title>
   	 <description>Persistent ocular tremors that prevent eye stability during fixation appear to be common among patients with Parkinson disease (PD) suggesting that precise oculomotor testing could provide an early physiological biomarker for diagnosing PD, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-04-persistent-ocular-tremors-parkinson-disease.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Mon, 09 Apr 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news253189649</guid>
	 
</item>
<item>
     <title>Study examines immunotherapy and cerebrospinal fluid biomarkers in patients with Alzheimer's disease</title>
   	 <description>Immunotherapy with the antibody bapineuzumab in patients with mild to moderate Alzheimer disease resulted in decreases in a cerebrospinal fluid biomarker, which may indicate downstream effects on the degenerative process, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-04-immunotherapy-cerebrospinal-fluid-biomarkers-patients.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 02 Apr 2012 16:00:06 EST</pubDate>
	 <guid isPermaLink="false">news252590312</guid>
	 
</item>
<item>
     <title>Study examines link between blood biomarkers and risk of Alzheimer's disease</title>
   	 <description>A meta-analysis of previously published studies found that the ratio of blood plasma amyloid-&amp;#946; (A&amp;#946;) peptides A&amp;#946;42:A&amp;#946;40 was significantly associated with development of Alzheimer disease and dementia, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-03-link-blood-biomarkers-alzheimer-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 26 Mar 2012 16:00:14 EST</pubDate>
	 <guid isPermaLink="false">news251985816</guid>
	 
</item>
<item>
     <title>Asian origins of Machado-Joseph disease revealed</title>
   	 <description>(Medical Xpress) -- Knowledge of a disease prevalent among Northern Territory Indigenous communities has been overhauled thanks to research contributed by the University of Sydney's Garth Nicholson.</description>
     <link>http://medicalxpress.com/news/2012-03-asian-machado-joseph-disease-revealed.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 09 Mar 2012 06:50:01 EST</pubDate>
	 <guid isPermaLink="false">news250497215</guid>
	 
</item>
<item>
     <title>Brain-imaging technique predicts who will suffer cognitive decline over time</title>
   	 <description>Cognitive loss and brain degeneration currently affect millions of adults, and the number will increase, given the population of aging baby boomers. Today, nearly 20 percent of people age 65 or older suffer from mild cognitive impairment and 10 percent have dementia.</description>
     <link>http://medicalxpress.com/news/2012-02-brain-imaging-technique-cognitive-decline.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 13 Feb 2012 16:00:05 EST</pubDate>
	 <guid isPermaLink="false">news248370873</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/brainimaging.jpg" width="90" height="90" />
</item>
<item>
     <title>Revised criteria could reclassify many with mild Alzheimer dementia</title>
   	 <description>Many patients currently diagnosed with very mild or mild Alzheimer disease dementia could potentially be reclassified as having mild cognitive impairment (MCI) under revised criteria for that condition, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-02-criteria-reclassify-mild-alzheimer-dementia.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 06 Feb 2012 16:00:06 EST</pubDate>
	 <guid isPermaLink="false">news247756138</guid>
	 
</item>
<item>
     <title>Active lifestyle associated with less Alzheimer disease-related brain change among persons with APOE epsilon4 genotype</title>
   	 <description>A sedentary lifestyle is associated with greater cerebral amyloid deposition, which is characteristic of Alzheimer&amp;#146;s disease (AD), among cognitively normal individuals with the &amp;#949;4 allele of the apolipoprotein E (APOE) gene, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.</description>
     <link>http://medicalxpress.com/news/2012-01-lifestyle-alzheimer-disease-related-brain-persons.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 16 Jan 2012 06:40:01 EST</pubDate>
	 <guid isPermaLink="false">news245916858</guid>
	 
</item>
<item>
     <title>Demographic, clinical factors appear associated with survival in patients with Parkinson's disease</title>
   	 <description>Demographics and clinical factors appear to be associated with survival in patients with Parkinson disease (PD), and the presence of dementia is associated with a significant increase in mortality, according to a report in the January issue of Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-01-demographic-clinical-factors-survival-patients.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Mon, 02 Jan 2012 16:00:04 EST</pubDate>
	 <guid isPermaLink="false">news244731482</guid>
	 
</item>
<item>
     <title>A second 'bad' gene is linked to damaged cell buildup, paralysis in ALS</title>
   	 <description>Following a major Northwestern Medicine breakthrough that identified a common converging point for all forms of amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease), a new finding from the same scientists further broadens the understanding of why cells in the brain and spinal cord degenerate in the fatal disease.</description>
     <link>http://medicalxpress.com/news/2011-11-bad-gene-linked-cell-buildup.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 21 Nov 2011 16:20:19 EST</pubDate>
	 <guid isPermaLink="false">news241114788</guid>
	 
</item>
<item>
     <title>Small study shows association between medication and reduction in brain amyloid levels related to AD</title>
   	 <description>Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2011-10-small-association-medication-reduction-brain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 10 Oct 2011 16:00:11 EST</pubDate>
	 <guid isPermaLink="false">news237468335</guid>
	 
</item>
<item>
     <title>Marker for Alzheimer's disease rises during day and falls with sleep</title>
   	 <description>A marker for Alzheimer's disease rises and falls in the spinal fluid in a daily pattern that echoes the sleep cycle, researchers at Washington University School of Medicine in St. Louis have found.</description>
     <link>http://medicalxpress.com/news/2011-09-marker-alzheimer-disease-day-falls.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 26 Sep 2011 16:22:03 EST</pubDate>
	 <guid isPermaLink="false">news236272899</guid>
	 
</item>
<item>
     <title>Study finds no link between intracerebral hemorrhage and statin use among patients with prior stroke</title>
   	 <description>Among patients who have had an ischemic stroke, use of cholesterol-lowering statin medications is not associated with subsequent intracerebral hemorrhage (bleeding in the brain), according to a report published Online First by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2011-09-link-intracerebral-hemorrhage-statin-patients.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 12 Sep 2011 16:51:06 EST</pubDate>
	 <guid isPermaLink="false">news235065048</guid>
	 
</item>
<item>
     <title>Study evaluates intranasal insulin therapy for adults with mild cognitive impairment or Alzheimer's</title>
   	 <description>Intranasal insulin therapy appears to provide some benefit for cognitive function in patients with amnestic mild cognitive impairment and Alzheimer disease, according to a report published Online First today by Archives of Neurology.</description>
     <link>http://medicalxpress.com/news/2011-09-intranasal-insulin-therapy-adults-mild.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 12 Sep 2011 16:49:53 EST</pubDate>
	 <guid isPermaLink="false">news235064405</guid>
	 
</item>
<item>
     <title>Deep brain stimulation effects may last for 10 years in patients with Parkinson's disease</title>
   	 <description>One decade after receiving implants that stimulate areas of their brains, patients with Parkinson's disease (PD) appear to sustain improvement in motor function, although part of the initial benefit wore off mainly because of progressive loss of benefit in other functions, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.</description>
     <link>http://medicalxpress.com/news/2011-08-deep-brain-effects-years-patients.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 08 Aug 2011 16:20:01 EST</pubDate>
	 <guid isPermaLink="false">news232031065</guid>
	 
</item>


</channel>
</rss>
